AIN
Scorpion Venom Biotech

Scorpion Venom Biotech

location_on Slovenia

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

EU-based biotech venture in Slovenia building a scorpion farming facility for biomaterial collection and peptide production for research. Initial funding target £150,000 to launch operations, with total project funding of £300,000 raised in stages.

Highlights

  • EU-based biotech in Slovenia ensuring transparent and ethical production.
  • Innovative extraction of high-value scorpion venom for pharma and research.
  • Global demand exceeds supply — strong market opportunity in EU biotech.
  • Clear path to revenue with first production within 15–18 months.
  • Profit-share model: investors receive 20% of net profit.

Overview

Target €175,000
Minimum €6,000
Investment Raised €10,000
Previous Rounds €0
Stage Pre-Startup/R&D
Investor Role Silent

Ask a question
Got a question about this project?

Similar Projects